Black Friday Deals with Eden. Unlock the New You, Today!
Get started
Get Started
Weight Loss

How Do Semaglutide Tablets Work? Safety and Effectiveness

Learn how semaglutide tablets work to manage weight and control blood sugar in type 2 diabetes. Discover their safety, effectiveness, and whether they're the right choice for you.

Clinically proven

weight loss treatment

Compounded Semaglutide

As low as  
$176
/mo
As low as  
$276
/mo
In stock
Limited supply
Semaglutide

Compounded Semaglutide & MIC+B12

As low as  
$276
/mo
As low as  
$296
/mo
In stock
Limited supply
Semaglutide

Compounded Semaglutide & Sermorelin

As low as  
/mo
As low as  
$406
/mo
In stock
Limited supply
Semaglutide

Compounded Semaglutide & Sermorelin & MIC+B12

As low as  
/mo
As low as  
$476
/mo
In stock
Limited supply
Semaglutide

Oral Semaglutide

As low as  
/mo
As low as  
/mo
$246/mo
$196/1st mo
$246/mo
In stock
Limited supply
Semaglutide

Ozempic®

As low as  
/mo
As low as  
/mo
$1,399/mo
$1,399/mo
In stock
Limited supply
Semaglutide

Wegovy®

As low as  
/mo
As low as  
/mo
$1,695/mo
$1,695/mo
In stock
Limited supply
Semaglutide

Mounjaro®

As low as  
/mo
As low as  
/mo
$1,399/mo
$1,399/mo
In stock
Limited supply
Tirzepatide

Zepbound®

As low as  
/mo
As low as  
/mo
$1,399/mo
$1,399/mo
In stock
Limited supply
Tirzepatide

Overview

This article explores how semaglutide tablets, like Rybelsus®, help with weight loss and glycemic control in adults with type 2 diabetes. It explains how these GLP-1 receptor agonists work by increasing insulin release, reducing appetite, and slowing gastric emptying. The article also compares the effectiveness of semaglutide tablets to the injectable form, highlighting the pros and cons of each.

Have you ever wondered how semaglutide tablets work to help with weight loss and glycemic control? These innovative medications have been revolutionizing the treatment of obesity and type 2 diabetes. As a GLP-1 receptor agonist, semaglutide influences your body's natural processes to regulate appetite and blood sugar levels. Understanding how oral semaglutide works can give you insight into its potential benefits and risks.

Key Takeaways

  • Semaglutide tablets, sold under the brand name Rybelsus®, are an oral GLP-1 receptor agonist used to help control blood sugar levels in adults with type 2 diabetes. They work by increasing insulin release, lowering glucagon release, and delaying gastric emptying.
  • Semaglutide tablets are taken once daily, at least 30 minutes before your first food, beverage, or other oral medications. 
  • The recommended starting dose of semaglutide tablets is 3 mg once daily for 30 days. After 30 days, the dose may be increased to 7 mg once daily. If additional glycemic control is needed after at least 30 days on the 7 mg dose, the dose may be increased to 14 mg once daily.
  • Common side effects of semaglutide tablets include nausea, diarrhea, vomiting, abdominal pain, and constipation. More serious side effects can include pancreatitis, changes in vision, low blood sugar, kidney problems, and serious adverse events.
  • Semaglutide tablets are not recommended for use with other GLP-1 receptor agonists or other products intended for weight loss. They should also be used with caution in people with a history of pancreatitis or severe gastrointestinal disease.
  • If you miss a dose of semaglutide tablets, skip the missed dose and take your next dose at the regularly scheduled time. Do not take two doses of semaglutide tablets at the same time.
  • Store semaglutide tablets at room temperature (68°F to 77°F), in a dry place, and in the original bottle to protect them from moisture. Keep them out of reach of children.

What are Semaglutide Tablets?

Oral semaglutide tablets, sold under the brand name Rybelsus®, are an oral glucagon-like peptide-1 (GLP-1) receptor agonist used to help control blood sugar levels in adults with type 2 diabetes. As a GLP-1 receptor agonist, semaglutide has an influence on your body's natural processes to regulate appetite and blood sugar levels.

Semaglutide works by increasing insulin release, lowering glucagon release, and delaying gastric emptying. This innovative medication has revolutionized the treatment of obesity and type 2 diabetes. 

Semaglutide Tablets vs Injections: What are the Differences?

Semaglutide is available in both oral tablet and injectable forms, giving you options for managing your weight and blood sugar levels. Understanding the differences between these two forms can help you decide which one may be right for you.

The main difference between semaglutide tablets and injections is the route of administration. Oral semaglutide, sold under the brand name Rybelsus®, is taken once daily by mouth. Injectable semaglutide, available as Ozempic® and Wegovy®, is administered once weekly via subcutaneous injection. Both forms of semaglutide are similarly effective for weight loss and glycemic control. 

It's important to remember that not all semaglutide formulations have FDA approval for weight loss. Ozempic® and Rybelsus® are currently only indicated for the treatment of type 2 diabetes, although doctors may prescribe them off-label for weight management. Wegovy® is the only semaglutide product specifically approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition.

Is Oral Semaglutide as Effective as the Injectable Form?

Oral semaglutide (SubMagna™ and Rybelsus®) may be as effective as the injectable form (Wegovy® vs Ozempic®) for glycemic control and weight loss. A 2021 research review that analyzed several clinical trials found that once-daily oral semaglutide is as or more effective than injectable versions of semaglutide and other GLP-1 receptor agonists for reducing A1C levels in people with diabetes.

The review also highlighted that oral semaglutide offers "similar or better efficacy and similar tolerability" compared to most injectable GLP-1s. This suggests that the oral formulation can provide comparable benefits while being more convenient for some patients who prefer to avoid injections.

Currently, only Wegovy® (injectable semaglutide) has received FDA approval for chronic weight management in adults with obesity or overweight with at least one weight-related condition. Ozempic® and Rybelsus® are indicated for the treatment of type 2 diabetes, although doctors may prescribe them off-label for use as a semaglutide weight loss option.

More research is needed to directly compare the effectiveness of oral versus injectable semaglutide, particularly in individuals without diabetes. The existing studies have primarily focused on glycemic control in people with type 2 diabetes, and factors such as background insulin therapy could influence the results.

As obesity continues to be a growing health concern, the potential of semaglutide in both oral and injectable forms to support weight loss is noteworthy. By helping individuals achieve and maintain a healthy weight, semaglutide may reduce the risk of serious health conditions associated with obesity, such as heart disease, stroke, and certain types of cancer.

When to Choose Semaglutide Tablets Over the Injectable Form

You may wonder when choosing semaglutide tablets over the injectable form is best. Here are a few scenarios where the oral version may be a better fit for you:

Scenario #1

If you have a strong aversion to needles or injections, semaglutide tablets provide an effective alternative. The convenience of taking a pill once daily can be appealing, especially if you struggle with the idea of self-administering injections regularly.

Remember that semaglutide tablets offer a needle-free option but have specific timing and administration requirements. You must take the tablet on an empty stomach first thing in the morning. You must also wait at least 30 minutes before eating, drinking, or taking any other medications.

Scenario #2

If you're already taking multiple oral medications for diabetes or other health conditions, adding semaglutide tablets to your regimen may be more convenient than incorporating an injectable medication. It's important to consider the timing of your other medications and closely follow the administration guidelines for semaglutide tablets.

Remember that certain medications, such as levothyroxine or oral bisphosphonates, may interact with semaglutide tablets or require specific timing for optimal absorption. Always discuss your complete medication list with your healthcare provider to ensure proper administration and avoid potential interactions.

Scenario #3

If you have difficulty adhering to a once-weekly injection schedule, the daily oral semaglutide regimen might be easier to remember and maintain. The key is establishing a consistent routine and following the administration guidelines closely.

Suppose you struggle with remembering to take medications on an empty stomach or have a variable morning routine—in that case, the once-weekly injectable form of semaglutide may be a better choice for you.

Ultimately, deciding between semaglutide tablets and injections depends on your preferences, lifestyle, and medical history. Discuss the pros and cons of each option with your healthcare provider to determine which form of semaglutide is best suited for your needs and goals in managing your type 2 diabetes and overall health.

How to Take Semaglutide Tablets: Dosing and Usage Guidelines

If you're starting semaglutide tablets, understanding the proper dosing and usage guidelines is essential to ensure optimal effectiveness and oral semaglutide safety. Here's what you need to know about taking this medication:

Dosing Schedule

  • The recommended starting dose of semaglutide tablets is 3 mg once daily for 30 days.
  • After 30 days, your doctor may increase the dose to 7 mg once daily.
  • If additional glycemic control is needed after at least 30 days on the 7 mg dose, your doctor may increase the dose to 14 mg once daily.
  • The maximum recommended dose is 14 mg per day. Taking two 7 mg tablets to achieve a 14 mg dose is not recommended.

Administration Instructions

To ensure proper absorption and effectiveness, follow these guidelines when taking semaglutide tablets:

  • Take the tablet on an empty stomach at least 30 minutes before your first food, beverage, or other oral medications.
  • Swallow the tablet whole with no more than 4 ounces (120 mL) of plain water.
  • Do not split, crush, or chew the tablet.
  • Wait at least 30 minutes after taking the tablet before eating, drinking, or taking other oral medications.
  • Waiting less than 30 minutes or taking the tablet with food, beverages other than plain water, or other oral medications will decrease absorption.
  • Waiting more than 30 minutes to eat may increase the absorption of semaglutide.

Missed Doses

If you miss a dose of semaglutide tablets, skip the missed dose and take your next dose at the regularly scheduled time. Do not take two doses at the same time to make up for a missed dose.

How to Store Semaglutide Tablets

Proper storage of semaglutide tablets is essential to protect the medication and ensure its effectiveness. Remember that storage instructions may vary depending on the specific brand of semaglutide you are prescribed.

For Rybelsus®, the oral tablet form of semaglutide, you should store the medication at room temperature. The manufacturer recommends keeping the tablets in their original bottle with the blue cap, which contains a drying agent to protect the pills from moisture.

If you are using injectable forms of semaglutide, such as Ozempic® or Wegovy®, storage requirements may differ:

  • Unused Ozempic® injection pens should be stored in the refrigerator. Once in use, they can be kept at room temperature or refrigerated for up to 56 days. After this time, discard any unused medication.
  • Wegovy® injection pens should be stored in the refrigerator. If necessary, unopened pens can be left at room temperature for up to 28 days. They also need to be protected from light.

It's important to note that both Wegovy® and Ozempic® should not be used if the medication has been frozen.

To ensure you are using your semaglutide medication safely and effectively, always follow the storage instructions provided by your doctor or pharmacist. They can help you locate your medication's expiration date and guide you on when to discard unused or expired doses.

Remember, proper storage helps maintain the potency and semaglutide safety of your tablets or injections, allowing you to get the most out of your treatment plan.

Common Side Effects of Oral Semaglutide

As with any medication, semaglutide tablets can cause side effects. The most common ones include nausea, stomach pain, diarrhea, decreased appetite, vomiting, and constipation. These gastrointestinal side effects tend to be most pronounced when you first start taking semaglutide or when your dose increases.

In studies, people taking semaglutide were more likely to experience gastrointestinal issues compared to those taking a placebo. Some individuals even stopped treatment because of these semaglutide side effects. It's essential to keep in mind that nausea, vomiting, and diarrhea can lead to dehydration, which could worsen existing kidney problems or cause acute kidney injury.

Some less common semaglutide side effects that may go away as your body adjusts to the medication include:

  • Acid reflux
  • Upset stomach
  • Belching
  • Excess gas
  • Feeling of pressure in the stomach
  • Heartburn
  • Stomach discomfort, swelling, tenderness, or upset

You may also experience changes in taste or loss of taste while taking semaglutide tablets. Talk to your healthcare provider if any side effects persist, worsen, or bother you. They may be able to suggest ways to manage these issues or adjust your treatment plan if needed.

Who Does Oral Semaglutide Work Well For?

Oral semaglutide can be an effective weight loss tool for a wide range of individuals struggling with obesity. According to research, this medication works well across various patient profiles, regardless of factors such as age, BMI, or race/ethnicity.

Suppose you have a BMI of 30 or higher, or a BMI of 27 or higher, along with a weight-related comorbidity like type 2 diabetes, high blood pressure, or high cholesterol. In that case, you may be a good candidate for semaglutide tablets. The medication's ability to suppress appetite and promote feelings of fullness can help you adhere to a reduced-calorie diet and achieve significant weight loss.

Semaglutide's efficacy in clinical trials suggests that it can benefit patients with obesity who have struggled to lose weight through lifestyle changes alone. By targeting the underlying biological mechanisms that contribute to weight gain, this medication offers a powerful adjunct to diet and exercise modifications.

It's important to note that semaglutide is not a magic pill. To achieve optimal results, you must commit to long-term changes in your eating habits and physical activity levels. Working closely with your healthcare provider, you can develop a comprehensive weight management plan incorporating semaglutide and other evidence-based strategies.

While semaglutide is generally well-tolerated, some individuals may be more prone to experiencing side effects like nausea, vomiting, or diarrhea. If you have a history of pancreatitis or medullary thyroid cancer, this medication may not be appropriate for you. 

Ultimately, the decision to use semaglutide for weight loss is a personal one that should be made in consultation with your healthcare team. By carefully weighing the potential benefits and risks, you can determine whether this innovative medication is right for you on your journey toward improved health and quality of life.

Who Should Avoid Oral Semaglutide?

While oral semaglutide can be an effective tool for managing type 2 diabetes and promoting weight loss, it's not suitable for everyone. You should avoid taking semaglutide tablets if you have certain health conditions or a history of specific medical issues.

People who should not use semaglutide include:

  • Those with a personal or family history of medullary thyroid carcinoma (MTC)
  • Individuals diagnosed with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • Anyone allergic to semaglutide or any of the ingredients in the specific product dispensed

It's crucial to discuss your current and past health conditions, as well as your family medical history, with your healthcare provider before starting semaglutide. Based on your unique circumstances, they can help determine whether this medication is appropriate for you.

In addition to these contraindications, there are several precautions to keep in mind when considering oral semaglutide:

  • Use caution if you have a history of pancreatitis, as semaglutide may not be the best choice for managing your type 2 diabetes.
  • If you have diabetic retinopathy or have experienced vision problems related to your diabetes, let your healthcare provider know. They may need to monitor your vision more closely while you're taking semaglutide.
  • Be aware of the potential for low blood sugar (hypoglycemia), especially if you're taking semaglutide alongside other diabetes medications like insulin or sulfonylureas.
  • Inform your doctor if you have kidney problems, as these may worsen while taking semaglutide.

Pregnancy and breastfeeding are also important considerations when it comes to oral semaglutide. If you're pregnant, planning to become pregnant, or breastfeeding, it's essential to talk to your healthcare provider about the potential risks and benefits of taking this medication.

Remember, your pharmacist can provide you with a complete list of the ingredients in your specific semaglutide product. Always discuss your complete medication list, including over-the-counter drugs, supplements, and herbal products, with your healthcare team to ensure safe and effective treatment.

FAQ

What if I Miss a Dose of Oral Semaglutide?

If you miss a dose of semaglutide tablets, skip the missed dose and take your next dose at the regularly scheduled time. Take only one dose of semaglutide tablets at a time to make up for a missed dose.

What Should I Look Out For on Semaglutide Tablets?

Common semaglutide side effects of semaglutide tablets include:

  • Nausea
  • Diarrhea
  • Vomiting
  • Abdominal pain
  • Constipation

More severe side effects can include pancreatitis, changes in vision, low blood sugar, kidney problems, and severe allergic reactions. If you experience any concerning symptoms while taking semaglutide tablets, contact your doctor right away.

Can I Take My Semaglutide Tablets if They've Expired?

No, you should not use semaglutide tablets past their expiration date. Always check your medication's expiration date and dispose of expired tablets properly. Using expired medicines can be ineffective or even harmful.

How Quickly Does Oral Semaglutide Work?

Semaglutide tablets start working on your body's natural processes to regulate appetite and blood sugar levels soon after you take them. It may take several weeks of consistent use to improve your A1C levels or weight significantly.

In clinical trials, people taking semaglutide tablets experienced reductions in A1C levels and body weight over several months. Keep in mind that individual results may vary, and it's important to take semaglutide tablets as prescribed by your healthcare provider for optimal effectiveness.

Final Thoughts on Semaglutide Tablets

Semaglutide tablets offer a promising option for managing type 2 diabetes and supporting weight loss efforts. Their ability to influence the body's natural processes to regulate appetite and blood sugar levels has revolutionized obesity and diabetes treatment. As with any medication, it's crucial to weigh the potential benefits against the risks and side effects, always following your healthcare provider's guidance for optimal results.

Semaglutide tablets, when combined with lifestyle changes, present a powerful tool in the fight against obesity and type 2 diabetes. While they've shown impressive results in clinical trials, it's important to remember that they're not a magic solution. A comprehensive approach, including a healthy diet and regular physical activity, remains essential to achieving and maintaining long-term health benefits.

References

Moll H, Frey E, Gerber P, et al. GLP-1 receptor agonists for weight reduction in people living with obesity but without diabetes: a living benefit–harm modelling study. EClinicalMedicine. 2024;73:102661-102661. doi https://doi.org/10.1016/j.eclinm.2024.102661

‌Wilding JPH, Batterham RL, Calanna S. Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine. 2021;384(11):989-1002. doi: https://doi.org/10.1056/NEJMoa2032183

‌Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet. 2021;397(10278):971-984. doi: https://doi.org/10.1016/s0140-6736(21)00213-0

‌Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA. 2021;325(14):1403-1413. doi: https://doi.org/10.1001/jama.2021.1831

‌Rubino D, Abrahamsson N, Davies M, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021;325(14):1414-1425. doi: https://doi.org/10.1001/jama.2021.3224

‌Garvey WT, Batterham RL, Bhatta M, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 2022;28(10):2083-2091. https://www.nature.com/articles/s41591-022-02026-4

‌Kadowaki T, Isendahl J, Khalid U, et al. Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial. The Lancet Diabetes & Endocrinology. 2022;10(3):193-206. doi: https://doi.org/10.1016/S2213-8587(22)00008-0

‌Gilson Dorneles, Algeri E, Lauterbach G, Pereira M, Fernandes B. Efficacy and safety of once-weekly subcutaneous semaglutide in adults with overweight or obesity: systematic review with meta-analysis. Experimental and clinical endocrinology & diabetes. Published online April 10, 2024. doi: https://doi.org/10.1055/a-2303-8558

‌Ruseva A, Michalak W, Zhao Z, Fabricatore A, Hartaigh BÓ, Umashanker D. Semaglutide 2.4 mg clinical outcomes in patients with obesity or overweight in a real-world setting: A 6-month retrospective study in the United States (SCOPE). Obesity Science & Practice. 2024;10(1):e737. doi: https://doi.org/10.1002/osp4.737

Wang W, Volkow ND, Berger NA, Davis PB, Kaelber DC, Xu R. Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population. Nature communications. 2024;15(1). doi: https://doi.org/10.1038/s41467-024-48780-6

‌Ryan DH, Lingvay I, Deanfield J, et al. Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial. Nature Medicine. Published online May 13, 2024:1-9. doi: https://doi.org/10.1038/s41591-024-02996-7

‌Song CE, Wang Y, Dai XM, Wu HY. Efficacy and Safety of Semaglutide in Weight Loss of Non-diabetic People. Endocrine Metabolic & Immune Disorders - Drug Targets. 2024;24. doi: https://doi.org/10.2174/0118715303283400240521120048

Disclaimer: The FDA does not approve compounded medications for safety, quality opr manufacturing practices. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects, or consequences resulting from the use of any suggestions or information provided in this blog.

Disclaimer:The information provided on this blog is for general informational purposesonly. It is not intended as a substitute for professional advice from aqualified healthcare professional and should not be relied upon as personalhealth advice. The information contained in this blog is not meant to diagnose,treat, cure, or prevent any disease. Readers are advised to consult with aqualified healthcare professional for any medical concerns. Use of this blog'sinformation is at your own risk. The blog owner is not responsible for anyadverse effects, or consequences resulting from the use of any suggestions orinformation provided in this blog.

Clinically proven weight loss treatments

GLP-1 medications

Starting at $179/mo
No items found.

Start your health journey now

On-demand medical support, 100% online
Transparent pricing for every single dose
Tested lots for potency, sterility, pH and endotoxicity
Transparent pricing for every single dose
Weight Loss
How Do Semaglutide Tablets Work? Safety and Effectiveness
Full name
November 2, 2024
5
 min read

Have you ever wondered how semaglutide tablets work to help with weight loss and glycemic control? These innovative medications have been revolutionizing the treatment of obesity and type 2 diabetes. As a GLP-1 receptor agonist, semaglutide influences your body's natural processes to regulate appetite and blood sugar levels. Understanding how oral semaglutide works can give you insight into its potential benefits and risks.

Key Takeaways

  • Semaglutide tablets, sold under the brand name Rybelsus®, are an oral GLP-1 receptor agonist used to help control blood sugar levels in adults with type 2 diabetes. They work by increasing insulin release, lowering glucagon release, and delaying gastric emptying.
  • Semaglutide tablets are taken once daily, at least 30 minutes before your first food, beverage, or other oral medications. 
  • The recommended starting dose of semaglutide tablets is 3 mg once daily for 30 days. After 30 days, the dose may be increased to 7 mg once daily. If additional glycemic control is needed after at least 30 days on the 7 mg dose, the dose may be increased to 14 mg once daily.
  • Common side effects of semaglutide tablets include nausea, diarrhea, vomiting, abdominal pain, and constipation. More serious side effects can include pancreatitis, changes in vision, low blood sugar, kidney problems, and serious adverse events.
  • Semaglutide tablets are not recommended for use with other GLP-1 receptor agonists or other products intended for weight loss. They should also be used with caution in people with a history of pancreatitis or severe gastrointestinal disease.
  • If you miss a dose of semaglutide tablets, skip the missed dose and take your next dose at the regularly scheduled time. Do not take two doses of semaglutide tablets at the same time.
  • Store semaglutide tablets at room temperature (68°F to 77°F), in a dry place, and in the original bottle to protect them from moisture. Keep them out of reach of children.

What are Semaglutide Tablets?

Oral semaglutide tablets, sold under the brand name Rybelsus®, are an oral glucagon-like peptide-1 (GLP-1) receptor agonist used to help control blood sugar levels in adults with type 2 diabetes. As a GLP-1 receptor agonist, semaglutide has an influence on your body's natural processes to regulate appetite and blood sugar levels.

Semaglutide works by increasing insulin release, lowering glucagon release, and delaying gastric emptying. This innovative medication has revolutionized the treatment of obesity and type 2 diabetes. 

Semaglutide Tablets vs Injections: What are the Differences?

Semaglutide is available in both oral tablet and injectable forms, giving you options for managing your weight and blood sugar levels. Understanding the differences between these two forms can help you decide which one may be right for you.

The main difference between semaglutide tablets and injections is the route of administration. Oral semaglutide, sold under the brand name Rybelsus®, is taken once daily by mouth. Injectable semaglutide, available as Ozempic® and Wegovy®, is administered once weekly via subcutaneous injection. Both forms of semaglutide are similarly effective for weight loss and glycemic control. 

It's important to remember that not all semaglutide formulations have FDA approval for weight loss. Ozempic® and Rybelsus® are currently only indicated for the treatment of type 2 diabetes, although doctors may prescribe them off-label for weight management. Wegovy® is the only semaglutide product specifically approved for chronic weight management in adults with obesity or overweight with at least one weight-related condition.

Is Oral Semaglutide as Effective as the Injectable Form?

Oral semaglutide (SubMagna™ and Rybelsus®) may be as effective as the injectable form (Wegovy® vs Ozempic®) for glycemic control and weight loss. A 2021 research review that analyzed several clinical trials found that once-daily oral semaglutide is as or more effective than injectable versions of semaglutide and other GLP-1 receptor agonists for reducing A1C levels in people with diabetes.

The review also highlighted that oral semaglutide offers "similar or better efficacy and similar tolerability" compared to most injectable GLP-1s. This suggests that the oral formulation can provide comparable benefits while being more convenient for some patients who prefer to avoid injections.

Currently, only Wegovy® (injectable semaglutide) has received FDA approval for chronic weight management in adults with obesity or overweight with at least one weight-related condition. Ozempic® and Rybelsus® are indicated for the treatment of type 2 diabetes, although doctors may prescribe them off-label for use as a semaglutide weight loss option.

More research is needed to directly compare the effectiveness of oral versus injectable semaglutide, particularly in individuals without diabetes. The existing studies have primarily focused on glycemic control in people with type 2 diabetes, and factors such as background insulin therapy could influence the results.

As obesity continues to be a growing health concern, the potential of semaglutide in both oral and injectable forms to support weight loss is noteworthy. By helping individuals achieve and maintain a healthy weight, semaglutide may reduce the risk of serious health conditions associated with obesity, such as heart disease, stroke, and certain types of cancer.

When to Choose Semaglutide Tablets Over the Injectable Form

You may wonder when choosing semaglutide tablets over the injectable form is best. Here are a few scenarios where the oral version may be a better fit for you:

Scenario #1

If you have a strong aversion to needles or injections, semaglutide tablets provide an effective alternative. The convenience of taking a pill once daily can be appealing, especially if you struggle with the idea of self-administering injections regularly.

Remember that semaglutide tablets offer a needle-free option but have specific timing and administration requirements. You must take the tablet on an empty stomach first thing in the morning. You must also wait at least 30 minutes before eating, drinking, or taking any other medications.

Scenario #2

If you're already taking multiple oral medications for diabetes or other health conditions, adding semaglutide tablets to your regimen may be more convenient than incorporating an injectable medication. It's important to consider the timing of your other medications and closely follow the administration guidelines for semaglutide tablets.

Remember that certain medications, such as levothyroxine or oral bisphosphonates, may interact with semaglutide tablets or require specific timing for optimal absorption. Always discuss your complete medication list with your healthcare provider to ensure proper administration and avoid potential interactions.

Scenario #3

If you have difficulty adhering to a once-weekly injection schedule, the daily oral semaglutide regimen might be easier to remember and maintain. The key is establishing a consistent routine and following the administration guidelines closely.

Suppose you struggle with remembering to take medications on an empty stomach or have a variable morning routine—in that case, the once-weekly injectable form of semaglutide may be a better choice for you.

Ultimately, deciding between semaglutide tablets and injections depends on your preferences, lifestyle, and medical history. Discuss the pros and cons of each option with your healthcare provider to determine which form of semaglutide is best suited for your needs and goals in managing your type 2 diabetes and overall health.

How to Take Semaglutide Tablets: Dosing and Usage Guidelines

If you're starting semaglutide tablets, understanding the proper dosing and usage guidelines is essential to ensure optimal effectiveness and oral semaglutide safety. Here's what you need to know about taking this medication:

Dosing Schedule

  • The recommended starting dose of semaglutide tablets is 3 mg once daily for 30 days.
  • After 30 days, your doctor may increase the dose to 7 mg once daily.
  • If additional glycemic control is needed after at least 30 days on the 7 mg dose, your doctor may increase the dose to 14 mg once daily.
  • The maximum recommended dose is 14 mg per day. Taking two 7 mg tablets to achieve a 14 mg dose is not recommended.

Administration Instructions

To ensure proper absorption and effectiveness, follow these guidelines when taking semaglutide tablets:

  • Take the tablet on an empty stomach at least 30 minutes before your first food, beverage, or other oral medications.
  • Swallow the tablet whole with no more than 4 ounces (120 mL) of plain water.
  • Do not split, crush, or chew the tablet.
  • Wait at least 30 minutes after taking the tablet before eating, drinking, or taking other oral medications.
  • Waiting less than 30 minutes or taking the tablet with food, beverages other than plain water, or other oral medications will decrease absorption.
  • Waiting more than 30 minutes to eat may increase the absorption of semaglutide.

Missed Doses

If you miss a dose of semaglutide tablets, skip the missed dose and take your next dose at the regularly scheduled time. Do not take two doses at the same time to make up for a missed dose.

How to Store Semaglutide Tablets

Proper storage of semaglutide tablets is essential to protect the medication and ensure its effectiveness. Remember that storage instructions may vary depending on the specific brand of semaglutide you are prescribed.

For Rybelsus®, the oral tablet form of semaglutide, you should store the medication at room temperature. The manufacturer recommends keeping the tablets in their original bottle with the blue cap, which contains a drying agent to protect the pills from moisture.

If you are using injectable forms of semaglutide, such as Ozempic® or Wegovy®, storage requirements may differ:

  • Unused Ozempic® injection pens should be stored in the refrigerator. Once in use, they can be kept at room temperature or refrigerated for up to 56 days. After this time, discard any unused medication.
  • Wegovy® injection pens should be stored in the refrigerator. If necessary, unopened pens can be left at room temperature for up to 28 days. They also need to be protected from light.

It's important to note that both Wegovy® and Ozempic® should not be used if the medication has been frozen.

To ensure you are using your semaglutide medication safely and effectively, always follow the storage instructions provided by your doctor or pharmacist. They can help you locate your medication's expiration date and guide you on when to discard unused or expired doses.

Remember, proper storage helps maintain the potency and semaglutide safety of your tablets or injections, allowing you to get the most out of your treatment plan.

Common Side Effects of Oral Semaglutide

As with any medication, semaglutide tablets can cause side effects. The most common ones include nausea, stomach pain, diarrhea, decreased appetite, vomiting, and constipation. These gastrointestinal side effects tend to be most pronounced when you first start taking semaglutide or when your dose increases.

In studies, people taking semaglutide were more likely to experience gastrointestinal issues compared to those taking a placebo. Some individuals even stopped treatment because of these semaglutide side effects. It's essential to keep in mind that nausea, vomiting, and diarrhea can lead to dehydration, which could worsen existing kidney problems or cause acute kidney injury.

Some less common semaglutide side effects that may go away as your body adjusts to the medication include:

  • Acid reflux
  • Upset stomach
  • Belching
  • Excess gas
  • Feeling of pressure in the stomach
  • Heartburn
  • Stomach discomfort, swelling, tenderness, or upset

You may also experience changes in taste or loss of taste while taking semaglutide tablets. Talk to your healthcare provider if any side effects persist, worsen, or bother you. They may be able to suggest ways to manage these issues or adjust your treatment plan if needed.

Who Does Oral Semaglutide Work Well For?

Oral semaglutide can be an effective weight loss tool for a wide range of individuals struggling with obesity. According to research, this medication works well across various patient profiles, regardless of factors such as age, BMI, or race/ethnicity.

Suppose you have a BMI of 30 or higher, or a BMI of 27 or higher, along with a weight-related comorbidity like type 2 diabetes, high blood pressure, or high cholesterol. In that case, you may be a good candidate for semaglutide tablets. The medication's ability to suppress appetite and promote feelings of fullness can help you adhere to a reduced-calorie diet and achieve significant weight loss.

Semaglutide's efficacy in clinical trials suggests that it can benefit patients with obesity who have struggled to lose weight through lifestyle changes alone. By targeting the underlying biological mechanisms that contribute to weight gain, this medication offers a powerful adjunct to diet and exercise modifications.

It's important to note that semaglutide is not a magic pill. To achieve optimal results, you must commit to long-term changes in your eating habits and physical activity levels. Working closely with your healthcare provider, you can develop a comprehensive weight management plan incorporating semaglutide and other evidence-based strategies.

While semaglutide is generally well-tolerated, some individuals may be more prone to experiencing side effects like nausea, vomiting, or diarrhea. If you have a history of pancreatitis or medullary thyroid cancer, this medication may not be appropriate for you. 

Ultimately, the decision to use semaglutide for weight loss is a personal one that should be made in consultation with your healthcare team. By carefully weighing the potential benefits and risks, you can determine whether this innovative medication is right for you on your journey toward improved health and quality of life.

Who Should Avoid Oral Semaglutide?

While oral semaglutide can be an effective tool for managing type 2 diabetes and promoting weight loss, it's not suitable for everyone. You should avoid taking semaglutide tablets if you have certain health conditions or a history of specific medical issues.

People who should not use semaglutide include:

  • Those with a personal or family history of medullary thyroid carcinoma (MTC)
  • Individuals diagnosed with Multiple Endocrine Neoplasia syndrome type 2 (MEN 2)
  • Anyone allergic to semaglutide or any of the ingredients in the specific product dispensed

It's crucial to discuss your current and past health conditions, as well as your family medical history, with your healthcare provider before starting semaglutide. Based on your unique circumstances, they can help determine whether this medication is appropriate for you.

In addition to these contraindications, there are several precautions to keep in mind when considering oral semaglutide:

  • Use caution if you have a history of pancreatitis, as semaglutide may not be the best choice for managing your type 2 diabetes.
  • If you have diabetic retinopathy or have experienced vision problems related to your diabetes, let your healthcare provider know. They may need to monitor your vision more closely while you're taking semaglutide.
  • Be aware of the potential for low blood sugar (hypoglycemia), especially if you're taking semaglutide alongside other diabetes medications like insulin or sulfonylureas.
  • Inform your doctor if you have kidney problems, as these may worsen while taking semaglutide.

Pregnancy and breastfeeding are also important considerations when it comes to oral semaglutide. If you're pregnant, planning to become pregnant, or breastfeeding, it's essential to talk to your healthcare provider about the potential risks and benefits of taking this medication.

Remember, your pharmacist can provide you with a complete list of the ingredients in your specific semaglutide product. Always discuss your complete medication list, including over-the-counter drugs, supplements, and herbal products, with your healthcare team to ensure safe and effective treatment.

FAQ

What if I Miss a Dose of Oral Semaglutide?

If you miss a dose of semaglutide tablets, skip the missed dose and take your next dose at the regularly scheduled time. Take only one dose of semaglutide tablets at a time to make up for a missed dose.

What Should I Look Out For on Semaglutide Tablets?

Common semaglutide side effects of semaglutide tablets include:

  • Nausea
  • Diarrhea
  • Vomiting
  • Abdominal pain
  • Constipation

More severe side effects can include pancreatitis, changes in vision, low blood sugar, kidney problems, and severe allergic reactions. If you experience any concerning symptoms while taking semaglutide tablets, contact your doctor right away.

Can I Take My Semaglutide Tablets if They've Expired?

No, you should not use semaglutide tablets past their expiration date. Always check your medication's expiration date and dispose of expired tablets properly. Using expired medicines can be ineffective or even harmful.

How Quickly Does Oral Semaglutide Work?

Semaglutide tablets start working on your body's natural processes to regulate appetite and blood sugar levels soon after you take them. It may take several weeks of consistent use to improve your A1C levels or weight significantly.

In clinical trials, people taking semaglutide tablets experienced reductions in A1C levels and body weight over several months. Keep in mind that individual results may vary, and it's important to take semaglutide tablets as prescribed by your healthcare provider for optimal effectiveness.

Final Thoughts on Semaglutide Tablets

Semaglutide tablets offer a promising option for managing type 2 diabetes and supporting weight loss efforts. Their ability to influence the body's natural processes to regulate appetite and blood sugar levels has revolutionized obesity and diabetes treatment. As with any medication, it's crucial to weigh the potential benefits against the risks and side effects, always following your healthcare provider's guidance for optimal results.

Semaglutide tablets, when combined with lifestyle changes, present a powerful tool in the fight against obesity and type 2 diabetes. While they've shown impressive results in clinical trials, it's important to remember that they're not a magic solution. A comprehensive approach, including a healthy diet and regular physical activity, remains essential to achieving and maintaining long-term health benefits.

References

Moll H, Frey E, Gerber P, et al. GLP-1 receptor agonists for weight reduction in people living with obesity but without diabetes: a living benefit–harm modelling study. EClinicalMedicine. 2024;73:102661-102661. doi https://doi.org/10.1016/j.eclinm.2024.102661

‌Wilding JPH, Batterham RL, Calanna S. Once-Weekly Semaglutide in Adults with Overweight or Obesity. The New England Journal of Medicine. 2021;384(11):989-1002. doi: https://doi.org/10.1056/NEJMoa2032183

‌Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2·4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial. The Lancet. 2021;397(10278):971-984. doi: https://doi.org/10.1016/s0140-6736(21)00213-0

‌Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity: The STEP 3 Randomized Clinical Trial. JAMA. 2021;325(14):1403-1413. doi: https://doi.org/10.1001/jama.2021.1831

‌Rubino D, Abrahamsson N, Davies M, et al. Effect of Continued Weekly Subcutaneous Semaglutide vs Placebo on Weight Loss Maintenance in Adults With Overweight or Obesity: The STEP 4 Randomized Clinical Trial. JAMA. 2021;325(14):1414-1425. doi: https://doi.org/10.1001/jama.2021.3224

‌Garvey WT, Batterham RL, Bhatta M, et al. Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial. Nature Medicine. 2022;28(10):2083-2091. https://www.nature.com/articles/s41591-022-02026-4

‌Kadowaki T, Isendahl J, Khalid U, et al. Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial. The Lancet Diabetes & Endocrinology. 2022;10(3):193-206. doi: https://doi.org/10.1016/S2213-8587(22)00008-0

‌Gilson Dorneles, Algeri E, Lauterbach G, Pereira M, Fernandes B. Efficacy and safety of once-weekly subcutaneous semaglutide in adults with overweight or obesity: systematic review with meta-analysis. Experimental and clinical endocrinology & diabetes. Published online April 10, 2024. doi: https://doi.org/10.1055/a-2303-8558

‌Ruseva A, Michalak W, Zhao Z, Fabricatore A, Hartaigh BÓ, Umashanker D. Semaglutide 2.4 mg clinical outcomes in patients with obesity or overweight in a real-world setting: A 6-month retrospective study in the United States (SCOPE). Obesity Science & Practice. 2024;10(1):e737. doi: https://doi.org/10.1002/osp4.737

Wang W, Volkow ND, Berger NA, Davis PB, Kaelber DC, Xu R. Associations of semaglutide with incidence and recurrence of alcohol use disorder in real-world population. Nature communications. 2024;15(1). doi: https://doi.org/10.1038/s41467-024-48780-6

‌Ryan DH, Lingvay I, Deanfield J, et al. Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial. Nature Medicine. Published online May 13, 2024:1-9. doi: https://doi.org/10.1038/s41591-024-02996-7

‌Song CE, Wang Y, Dai XM, Wu HY. Efficacy and Safety of Semaglutide in Weight Loss of Non-diabetic People. Endocrine Metabolic & Immune Disorders - Drug Targets. 2024;24. doi: https://doi.org/10.2174/0118715303283400240521120048

Disclaimer: The FDA does not approve compounded medications for safety, quality opr manufacturing practices. The information provided on this blog is for general informational purposes only. It is not intended as a substitute for professional advice from a qualified healthcare professional and should not be relied upon as personal health advice. The information contained in this blog is not meant to diagnose, treat, cure, or prevent any disease. Readers are advised to consult with a qualified healthcare professional for any medical concerns. Use of this blog's information is at your own risk. The blog owner is not responsible for any adverse effects, or consequences resulting from the use of any suggestions or information provided in this blog.

Disclaimer:The information provided on this blog is for general informational purposesonly. It is not intended as a substitute for professional advice from aqualified healthcare professional and should not be relied upon as personalhealth advice. The information contained in this blog is not meant to diagnose,treat, cure, or prevent any disease. Readers are advised to consult with aqualified healthcare professional for any medical concerns. Use of this blog'sinformation is at your own risk. The blog owner is not responsible for anyadverse effects, or consequences resulting from the use of any suggestions orinformation provided in this blog.

Share this post

Subscribe to our newsletter

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse varius enim in eros elementum tristique.

By clicking Sign Up you're confirming that you agree with our Terms and Conditions.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Everyday Eden

Featured Treatments

*Only available if prescribed after an online consultation with a healthcare provider. *Benefits outlined on TryEden are based on third-party studies. Plans are offered as a subscription service which you can cancel at any time. *Actual product packaging may appear differently than shown. Physicians may prescribe compounded medications as needed to meet patient requirements or drug shortages. *The FDA does not review or approve any compounded medications for safety or effectiveness. *Has not been approved by the FDA for these uses but studies have shown benefits. Results may vary.

The Science

Supporting research citations are below

1. Ozempic®, a GLP-1 receptor agonist, is approved for improving blood sugar control in adults with type 2 diabetes when used alongside diet and exercise. Clinical trials showed it effectively lowers HbA1c and body weight, regardless of sex, race, or age. While offering significant benefits, it may cause side effects like gastrointestinal issues, with serious risks including pancreatitis and potential cancer based on animal studies. The drug's efficacy and side effect profile were consistent across diverse demographic groups. Trials involved over 4,000 participants worldwide, further highlighting its global applicability and safety profile for a broad patient population.

1. Ozempic®, a GLP-1 receptor agonist, is approved for improving blood sugar control in adults with type 2 diabetes when used alongside diet and exercise. Clinical trials showed it effectively lowers HbA1c and body weight, regardless of sex, race, or age. While offering significant benefits, it may cause side effects like gastrointestinal issues, with serious risks including pancreatitis and potential cancer based on animal studies. The drug's efficacy and side effect profile were consistent across diverse demographic groups. Trials involved over 4,000 participants worldwide, further highlighting its global applicability and safety profile for a broad patient population.

1. Ozempic®, a GLP-1 receptor agonist, is approved for improving blood sugar control in adults with type 2 diabetes when used alongside diet and exercise. Clinical trials showed it effectively lowers HbA1c and body weight, regardless of sex, race, or age. While offering significant benefits, it may cause side effects like gastrointestinal issues, with serious risks including pancreatitis and potential cancer based on animal studies. The drug's efficacy and side effect profile were consistent across diverse demographic groups. Trials involved over 4,000 participants worldwide, further highlighting its global applicability and safety profile for a broad patient population.

Should you seek a prescription item, Eden will facilitate arranging a consultation with a qualified healthcare provider. This professional will assess your suitability for the prescription item. If deemed suitable, a doctor may issue a prescription for the item, which can be filled at a partner pharmacy, unless you specify an alternative preference.

Note: The above statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease.